Literature DB >> 18260022

[Surgical treatment of Duane's syndrome type I by recession of the medial rectus of the affected eye and faden operation of the contralateral medial rectus].

B Puerto-Hernández1, C López-Caballero, J M Rodríguez-Sánchez, M González-Manrique, I Contreras.   

Abstract

PURPOSE: Different surgical approaches have been described for the treatment of Duane's syndrome. The purpose of our study is to report the results of patients undergoing recession of the medial rectus (MR) muscle of the affected eye and placement of contralateral MR faden posterior fixation sutures.
METHODS: Retrospective study of 11 patients treated by a 4-7 mm recession of the MR of the affected eye and 13 mm faden posterior fixation suture of the contralateral MR in order to correct abnormal head position and esotropia in primary position.
RESULTS: After surgery, there was no torticolis in 81.8% of patients, with less than 10 degrees of torticolis in the remainder. In all patients, postoperative esotropia was less than 5 prismatic dioptres.
CONCLUSION: This is a safe and effective procedure in Duane's syndrome type I to treat moderate esotropia and torticolis.

Entities:  

Mesh:

Year:  2008        PMID: 18260022     DOI: 10.4321/s0365-66912008000200009

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  3 in total

1.  Contralateral lateral rectus muscle recession in patients with Duane retraction syndrome type 3.

Authors:  M Snir; A Dotan; R Friling; Y Ron-Kella; N Goldenberg-Cohen; H Stiebel-Kalish
Journal:  Eye (Lond)       Date:  2013-12-06       Impact factor: 3.775

2.  Outcomes in patients with esotropic duane retraction syndrome and a partially accommodative component.

Authors:  Ramesh Kekunnaya; Federico G Velez; Stacy L Pineles
Journal:  Indian J Ophthalmol       Date:  2013-12       Impact factor: 1.848

Review 3.  Surgical treatment of Duane retraction syndrome.

Authors:  Mohammad Reza Akbari; Vahideh Manouchehri; Arash Mirmohammadsadeghi
Journal:  J Curr Ophthalmol       Date:  2017-09-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.